Cholinergic Antagonists: Comprehensive Pharmacological and Clinical Study Guide

General Profiles of Cholinergic Antagonists

• Atropine serves as the prototypical cholinergic antagonist and specifically functions as a muscarinic blocker.

• Cholinergic antagonists or anticholinergics are categorized into two primary groups:

  • Antimuscarinic drugs: These include Atropine, Homatropine, Ipratropium, Scopolamine, Benztropine, and Pirenzepine.
  • Antinicotinic drugs: These are further subdivided into:
    • Ganglionic blockers: Target $N_n$ receptors at the neuron/ganglia level (Example: Hexamethonium).
    • Neuromuscular blockers: Target $N_m$ receptors at the neuromuscular junction (Example: Tubocurarine).

• Cholinesterase regenerators, such as Oximes (Pralidoxime), act indirectly by decreasing acetylcholine (ACh) levels, which is critical in treating organophosphorus poisoning.

Organ-Specific Responses to Anticholinergic Drugs

• Eye:

  • Effects include mydriasis (pupillary dilation) and cycloplegia (paralysis of the ciliary muscle), resulting in blurred vision.
  • In contrast, miosis refers to the constriction of the pupil to facilitate near vision by reducing light entry and enhancing resolution.
  • Near vision accommodation is the combined effect of miosis and ciliary muscle contraction (lens capacity adjustment).
  • Antimuscarinics cause passive mydriasis because the circular muscle (constrictor pupillae) is blocked, allowing the radial muscle to predominate. In contrast, active mydriasis occurs if the radial pupillae is directly stimulated.

• Skin:

  • Anticholinergics reduce sweating and cause flushing.
  • Sweating is a thermoregulatory mechanism essential for body temperature balance. Parasympathetic activation normally increases secretions, including sweat, lacrimation, and salivation.
  • Sweating can be both sympathetic (stress-related palm sweating) and parasympathetic (excessive body-wide sweating).
  • When sweating is inhibited, the body relies on vasodilation as its only thermoregulatory mechanism, which leads to skin flushing.

• Gastrointestinal (GI) System:

  • Effects include reduced motility, reduced secretions, and the contraction of sphincters.
  • These drugs are used to manage conditions like hypermotility and traveler’s diarrhea.

• Cardiovascular System:

  • The parasympathetic supply to the heart is directed at the SA node, AV node, and atria, with no supply reaching the ventricles.
  • The ultimate effect of high-dose atropine is increased heart rate.

• Respiratory System:

  • Activation of $M_3$ receptors in the bronchial tree leads to bronchoconstriction.
  • Antimuscarinics cause bronchial dilation and decreased secretions.

• Genitourinary (GU) System:

  • These drugs cause urinary retention and decreased urgency.
  • This occurs due to the reduction of detrusor muscle contraction and the increase in internal urinary sphincter tone.

• Central Nervous System (CNS):

  • CNS effects such as drowsiness, hallucinations, and coma only occur with anticholinergic drugs that can cross the blood-brain barrier (BBB).

Clinical Indications and Therapeutic Uses

• Central Nervous System Disorders:

  • Parkinson's Disease: Caused by the degeneration of dopaminergic neurons, leading to a predominance of cholinergic activity. Benztropine is used to mitigate tremors and pill-rolling movements (rhythmic involuntary rubbing of the thumb and index finger).
  • Motion Sickness: Scopolamine (Hyoscine) is one of the oldest agents used for this condition.

• Ophthalmology:

  • Measurement of refractive error: Requires ciliary paralysis.
  • Retinal/Fundus Examination: Short-acting mydriatic drugs like Cyclopentolate and Tropicamide are used to visualize the back of the eye for conditions like glaucoma, retinal detachment, diabetes, and hypertension.
  • Atropine and Homatropine are also used for eye examinations.

• Respiratory Disorders:

  • Ipratropium: A synthetic analog of Atropine administered by inhalation for asthma and Chronic Obstructive Pulmonary Disease (COPD), specifically for chronic smokers.
  • Tiotropium bromide: A related semisynthetic derivative.

• Cardiovascular Disorders:

  • Severe Heart Block: Characterized by bradycardia, low cardiac output, cold extremities, confusion, and a near-comatose state. Atropine is the preferred emergency treatment.
  • Isoproterenol may also be used in advanced medical facilities.

• Gastrointestinal Disorders:

  • Peptic Ulcer: Treated with selective $M_1$ blockers such as Pirenzepine or Telenzepine to decrease gastric acid secretions.

• Urinary Disorders:

  • Minor inflammatory bladder disorders (Cystitis): Reduced urgency when used with antimicrobial therapy.
  • Overactive Bladder: Managed with Oxybutynin to decrease involuntary voiding. $\beta_3$ agonists are also essential for this condition.

Detailed Pharmacology of Atropine

• Dose-Dependent Cardiovascular Effects:

  • Low Doses: Cause a slight decrease in heart rate. This is due to the blockade of $M_1$ receptors on inhibitory prejunctional (presynaptic) neurons, which permits increased ACh release.
  • Higher Doses: Cause a progressive increase in heart rate by blocking $M_2$ receptors on the sinoatrial node.

• BBB Permeability:

  • Tertiary amines (e.g., Atropine) are smaller, uncharged molecules that can pass the blood-brain barrier and produce CNS effects.
  • Quaternary ammonium compounds (e.g., Propantheline, Glycopyrrolate) are larger and polar, making them unable to cross the BBB.

• Natural Sources:

  • Atropine and Scopolamine are natural alkaloids found in plants like Datura. Datura was historically used to induce mydriasis for cosmetic purposes.

Cholinergic Poisoning and Toxicity Management

• Organophosphate Toxicity:
  • Characterized by severe parasympathetic manifestations.
  • Treatment requires a combination of:
    1. Antimuscarinic therapy: A tertiary amine like Atropine must be used to treat CNS effects.
    2. Cholinesterase regenerators: Compounds like Oximes (Pralidoxime).

Contraindications and Safety Warnings

• Ocular Contraindications:

  • Glaucoma: Specifically acute angle-closure glaucoma. Mydriasis obstructs aqueous humor drainage, leading to an increase in intraocular pressure (IOP) and potential vision loss.

• Urinary Contraindications:

  • Benign Prostatic Hyperplasia (BPH): A normal age-related enlargement of the prostate. Anticholinergics worsen urinary obstruction by reducing detrusor contraction and increasing sphincter tone, causing dripping or retention.

• Gastrointestinal Contraindications:

  • Paralytic Ileus: Anticholinergics worsen the condition by decreasing GI motility. Bethanechol (a cholinergic agonist) is used for treatment instead.

• Cardiac Contraindications:

  • Tachycardia: Due to the blockade of parasympathetic inhibition of the heart.

• General Risks:

  • Hyperthermia: Infants are particularly susceptible to hyperthermia from anticholinergics because their thermoregulatory systems are not fully developed.
  • Non-selective impacts: Some drugs like Tricyclic Antidepressants (TCAs), Phenothiazines, and Antihistamines exhibit significant anticholinergic side effects because they block muscarinic receptors in addition to their primary targets.

Questions and Discussion

• Why isn't Dobutamine used for heart block?
  • Dobutamine is preferred for heart failure rather than heart block. Heart block is primarily a defect in heart rate (conduction), whereas heart failure is a defect in contractility. Dobutamine specifically targets contractility.